Syros Pharmaceuticals Inc USD0.001

Sell:$0.00Buy:$0.00$0.00 (45.45%)

Prices delayed by at least 15 minutes
Sell:$0.00
Buy:$0.00
Change:$0.00 (45.45%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.00
Buy:$0.00
Change:$0.00 (45.45%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Syros Pharmaceuticals, Inc. is not engaged in any business activities. The Company is actively engaged in the voluntary delisting process. The Company was previously engaged in developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Key people

Kristin Stephens
Chief Development Officer
Gerald E. Quirk
Director
Click to see more

Key facts

  • EPIC
    SYRS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US87184Q2066
  • Market cap
    $29,520.00
  • Employees
    68
  • Shares in issue
    26.83m
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.